Vascular & Endovascular Surgery »  Meet the Team »  Division Chief »  Michael S. Conte, M.D.

Michael S. Conte, M.D.

Professor and Chief,
Division of Vascular & Endovascular Surgery
Edwin J. Wylie, M.D. Chair in Vascular Surgery
Co-Director, UCSF Heart and Vascular Center
Co-Director, UCSF Center for Limb Preservation

Contact Information

Division of Vascular and Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
Open Popup
  • 1978-82, Boston University, B.S., Biomedical Engineering
  • 1982-86, Albert Einstein College of Medicine, M.D., Medicine
  • 1986-88, New York Hospital, Cornell Medical Center, Junior Resident, General Surgery
  • 1988-89, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
  • 1991-92, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
  • 1992-93, New York Hospital, Cornell Medical Center, Chief Resident, General Surgery
  • 1989-91, Brigham and Women's Hospital/Harvard, Research Fellow, Vascular Surgery
  • 1993-94, Harvard Medical School, Fellow, Vascular Surgery
  • 1993-94, Brigham and Women's Hospital, Fellow, Vascular Surgery
  • American Board of Surgery, General Surgery, 1994
  • American Board of Surgery, Vascular Surgery, 1996
  • Cardiovascular Research Institute (CVRI)
  • UCSF Heart and Vascular Center

Dr. Michael Conte received his medical degree in 1986 at Albert Einstein College of Medicine. He completed his surgical residency at New York Hospital-Cornell Medical Center in 1993, which included a two year research fellowship at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology in Boston. He completed his vascular surgery training in 1994 as the John Homans Fellow at BWH and Harvard Medical School (HMS), in Boston.

Dr. Conte was an Assistant Professor of Surgery at Yale University from 1994-1997, and a member of the Boyer Center for Molecular Medicine. Subsequently he returned to BWH where he served as Assistant Professor (1997-2001) and then Associate Professor (2001-2008 ) of Surgery at HMS. From 2002-2008, he was the Director of Vascular Surgical Research at BWH and from 2005-2008, he was Co-Director of the Clinical Trials Group at the Center for Surgery and Public Health (a joint initiative between HMS, BWH, and the Harvard School for Public Health).

Dr. Conte is a member of many professional organizations, including the Society for Vascular Surgery and the Society of University Surgeons. Dr. Conte has also been an invited lecturer for many regional, national, and international meetings and conferences. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He is on the Editorial Board for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery, and Vascular. He has served as an Associate Editor for Circulation.

In 2017, Dr. Conte was named to Castle Connolly's list of the "Bay Area Top Doctors 2017" for Vascular Surgery.

  • Best Doctors in America, Best Doctors, Inc., 2015
  • T1 Catalyst Award Finalist, UCSF Clinical and Translational Sciences Institute (CTSI), 2012
  • Best Doctors in America, Best Doctors, Inc., 2009
  • Best Doctors in Boston, Best Doctors, Inc., 2007
  • Distinguished Achievement Award, New York Weill Cornell Medical Center Alumni Council, 2006
  • Mentored Clinical Scientist Development Award, NHLBI/Lifeline, 1999
  • Fellowship Award, American Surgical Association Foundation, 1997-1999
  • Research Award, Lifeline Foundation, 1988
  • Alpha Omega Alpha, Medical Honor Society, 1986
  • Tau Beta Pi, National Engineering Honor Society, 1982
View all

Dr. Conte's clinical interests include diseases of the aorta and its major branches, aneurysms, carotid artery disease, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization to preserve limb function and prevent amputation in patients with advanced forms of PAD. He had led the largest multicenter clinical trial to date examining the outcomes of leg bypass surgery in patients with severe PAD and is nationally and internationally recognized for his leadership in this area.

Dr. Conte's research is focused on developing new molecular therapies to improve the long-term results of cardiovascular procedures. His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.

  • 1.

  • NA

  • PI

  • Conte (PI)

  • Metagenics Inc

  • 09/01/2015

  • 08/31/2018

  • Specialized pro-resolving mediators in peripheral arterial disease

  • $ 301,447 direct/yr 1

  • $ 907,538 total

  • 2.

  • N/A

  • PI

  • N/A % effort

  • Conte (PI)

  • UC Center for Accelerated Innovation (CAI)

  • 8/1/2016

  • 7/31/2018

  • Pro-resolving micro/nano-particles to improve vascular patency

  • $ 130,032 direct/yr 1

  • $ 200,000 total

  • Technology Development Award to facilitate nanoparticle formulations of resolvin for application to vein bypass grafts and angioplasty treatments.

  • PI

  • 3.

  • 1R01HL119508-01

  • Principal Investigator

  • Conte (PI)


  • 08/21/2013

  • 05/31/2017

  • Specialized lipid mediators and mechanisms of resolution in vascular injury

  • $ 238,000 direct/yr 1

  • $ 988,000 total

  • 4.

  • HHSN268201400005C

  • Principal Investigator

  • Conte (PI)

  • NIH/NHLBI VITA Program Contract

  • 09/12/2013

  • 09/11/2016

  • Pro-resolving Vascular Devices

  • $ 200,000 direct/yr 1

  • $ 600,000 total

View all
Melinda Schaller, M.D. 7/2015 - 6/2017
Most recent publications from a total of 201
  1. Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, Berger JS, Held P, Katona BG, Mahaffey KW, Norgren L, Blomster J, Millegård M, Reist C, Patel MR, Fowkes GR. Ticagrelor Compared With Clopidogrel in Patients with Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation. 2016 Nov 13. View in PubMed
  2. Finnes HD, Chaffee KG, Call TG, Ding W, Kenderian SS, Bowen DA, Conte M, McCullough KB, Merten JA, Bartoo GT, Smith MD, Leis J, Chanan-Khan A, Schwager SM, Slager SL, Kay NE, Shanafelt TD, Parikh SA. Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice. Leuk Lymphoma. 2016 Nov 8; 1-8. View in PubMed
  3. Baldwin MJ, Policha A, Maldonado T, Hiramoto JS, Honig S, Conte MS, Berger J, Rockman CB. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes. Vasc Med. 2016 Oct 30. View in PubMed
  4. De Virgilio A, Greco A, Bussu F, Gallo A, Rosati D, Kim SH, Wang CC, Conte M, Pagliuca G, De Vincentiis M. Salvage total laryngectomy after conservation laryngeal surgery for recurrent laryngeal squamous cell carcinoma. Acta Otorhinolaryngol Ital. 2016 Oct; 36(5):373-380. View in PubMed
  5. Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G, Upchurch GR. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. FASEB J. 2016 Sep 12. View in PubMed
  6. Strati P, Lanasa M, Call TG, Leis JF, Brander DM, LaPlant BR, Pettinger AM, Ding W, Parikh SA, Hanson CA, Chanan-Khan AA, Bowen DA, Conte M, Kay NE, Shanafelt TD. Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial. Lancet Haematol. 2016 Sep; 3(9):e407-14. View in PubMed
  7. Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Hiramoto JS, Conte MS. Determinants of Midterm Functional Outcomes and Wound Healing in a Hospital-Based Limb Preservation Program. J Vasc Surg. 2016 Aug; 64(2):546-547. View in PubMed
  8. O'Banion LA, Wu B, Eichler CM, Reilly LM, Conte MS, Hiramoto JS. Cryopreserved Saphenous Vein: Last-Ditch Conduit for Limb Salvage? J Vasc Surg. 2016 Aug; 64(2):546. View in PubMed
  9. Menard MT, Farber A, Assmann SF, Choudhry NK, Conte MS, Creager MA, Dake MD, Jaff MR, Kaufman JA, Powell RJ, Reid DM, Siami FS, Sopko G, White CJ, Rosenfield K. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial. J Am Heart Assoc. 2016; 5(7). View in PubMed
  10. Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016 Jun; 63(6):1563-1573.e2. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Michael S. Conte, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.
  • John Maduell

    Conceptual Artist Retains Limb Against Long Odds

    John Maduell
    In his 33-year career as a conceptual artist at Lawrence Livermore National Laboratory, John Maduell illustrated futuristic technologies few others could imagine. But he never envisioned the toll diabetes and vascular disease would take on his body—or that one day he might lose his legs because of these problems.  Maduell's troubles started two years ago when he developed a diabetic ulcer on his left foot. "Before I knew it, I was in the hospital, with three toes amputated," he says. Still, the wound didn't heal, and Maduell, who now lives and paints in Modesto, was told removing the[...]
    Story Categories: Diabetic Foot UlcersDiabetic Peripheral NeuropathyPeripheral Artery Disease (PAD)
  • Bicknell Ramsay

    Multidisciplinary Cardiovascular Treatment Saves Limb

    Bicknell Ramsay — a 74-year-old retired engineer who lives a fully active life — was concerned that a wound on his foot would not heal. Having volunteered for a clinical study on peripheral artery disease (PAD), he described the wound to the principal investigator, UCSF nurse practitioner Roberta Oka, R.N., DNSc. She referred Ramsay to Michael S. Conte, M.D., (pictured at right on left), Chief of Vascular and Endovascular Surgery at UCSF Medical Center. By then, the wound exceeded two centimeters and was enlarging. After an ankle-brachial index test found only 30 percent of normal[...]
    Story Categories: Coronary Artery Bypass Grafting (CABG)Coronary Artery DiseaseCritical Limb IschemiaLower Extremity Bypass SurgeryPeripheral Artery Disease (PAD)